The Standard

Children with gender dysphoria could remain on puberty blockers after trial

trussliz

Sky News

Regulators approve first trials for puberty-blocking drugs in children since ban

BBC News

New puberty blockers clinical trial to begin after UK ban

Metaculus

When will there be an easily applied, reversible, male contraceptive (aka a male "pill") on the US market?

Guardian

I treat transgender children – banning puberty blockers is not a decision for politicians to make | Aidan Kelly

Pubmed

Puberty blockers for gender dysphoria in youth: A systematic review and meta-analysis

TransActual

TransActual statement on launch of puberty blocker trial  TransActual

Daily Mirror

Hundreds of children to be jabbed with puberty blockers in NHS-backed experiment

Daily Record

Scores of children to get puberty blockers on NHS in UK from 2026

Express.co.uk

Dozens of children to be given puberty blockers on NHS from 2026

Two UK clinical trials to assess impact of puberty blockers in young people

The Times

Children as young as 10 to be given puberty blockers in NHS trial

Independent

Puberty blockers to be tested in children as two major clinical studies launch

Daily Mail

Hundreds of children - some as young as 10 - are set to be jabbed with puberty blockers in NHS-backed experiment

The New Statesman

New puberty blocker trial approved for children, but questions remain

The Telegraph

Nhs Trans Drug Trial Betrays Our Children

Spectator (UK)

What are the conclusions of the Cass Review?

Researchers from King's College London have launched a clinical trial examining puberty blockers' impact on children with gender dysphoria, expecting to recruit 226 young people over three years with results anticipated in approximately four years.

Researchers from King's College London have launched a clinical trial examining puberty blockers' impact on children with gender dysphoria, expecting to recruit 226 young people over three years with results anticipated in approximately four years.

The trial follows the 2024 Cass Review, which concluded that research quality claiming benefits of puberty blockers for youngsters with gender dysphoria was poor, leading to a permanent NHS ban on prescribing these drugs to under-18s.

The trial follows the 2024 Cass Review, which concluded that research quality claiming benefits of puberty blockers for youngsters with gender dysphoria was poor, leading to a permanent NHS ban on prescribing these drugs to under-18s.

Participants will be divided into two groups — one receiving puberty blockers immediately for two years, another starting treatment after a one-year delay — with the youngest typically being 10-11 for girls and 11-12 for boys.

Participants will be divided into two groups — one receiving puberty blockers immediately for two years, another starting treatment after a one-year delay — with the youngest typically being 10-11 for girls and 11-12 for boys.

Children must have a diagnosis of gender incongruence for over two years, parental consent, and a persisting desire for treatment following psychological care to participate in the study led by Professor Emily Simonoff.

Children must have a diagnosis of gender incongruence for over two years, parental consent, and a persisting desire for treatment following psychological care to participate in the study led by Professor Emily Simonoff.

A companion study called Pathways Connect will examine brain development in approximately 250 young people, comparing those receiving puberty blockers with those accessing non-medical gender care through MRI imaging and cognitive tests.

A companion study called Pathways Connect will examine brain development in approximately 250 young people, comparing those receiving puberty blockers with those accessing non-medical gender care through MRI imaging and cognitive tests.

Some participants may continue taking puberty blockers after the trial ends if deemed clinically appropriate, despite the UK ban, while researchers monitor potential effects on bone health, fertility, and brain development throughout the study.

Some participants may continue taking puberty blockers after the trial ends if deemed clinically appropriate, despite the UK ban, while researchers monitor potential effects on bone health, fertility, and brain development throughout the study.

King's College Launches Puberty Blocker Trial After NHS Ban

King's College Launches Puberty Blocker Trial After NHS Ban

Go Deeper

Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

King's College Launches Puberty Blocker Trial After NHS Ban

King's College Launches Puberty Blocker Trial After NHS Ban

Go Deeper

Articles on this story

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters